Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
64.17
+0.54 (0.85%)
At close: May 22, 2026, 4:00 PM EDT
64.41
+0.24 (0.37%)
After-hours: May 22, 2026, 7:09 PM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $90.64. The average 1-year stock price forecast is 41.25% higher than the current stock price, while the lowest is $74 (+15.32%) and the highest is $122 (+90.12%).
Price Target: $90.64 (+41.25%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 5 | 5 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $90 → $85 | Strong Buy | Maintains | $90 → $85 | +32.46% | May 1, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $77 | Buy | Maintains | $95 → $77 | +19.99% | May 1, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $78 → $74 | Hold | Maintains | $78 → $74 | +15.32% | May 1, 2026 |
| Needham | Needham | Strong Buy Maintains $101 → $90 | Strong Buy | Maintains | $101 → $90 | +40.25% | May 1, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $109 → $107 | Buy | Maintains | $109 → $107 | +66.74% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
1.65B
from 1.52B
Increased by 8.98%
Revenue Next Year
1.75B
from 1.65B
Increased by 5.99%
EPS This Year
4.14
from 2.13
Increased by 94.47%
EPS Next Year
4.49
from 4.14
Increased by 8.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.7B | 1.8B | |||
| Avg | 1.7B | 1.8B | |||
| Low | 1.6B | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.7% | 9.8% | |||
| Avg | 9.0% | 6.0% | |||
| Low | 3.7% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.34 | 4.81 | |||
| Avg | 4.14 | 4.49 | |||
| Low | 3.92 | 4.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 103.6% | 16.1% | |||
| Avg | 94.5% | 8.4% | |||
| Low | 84.0% | 0.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.